ALAMAR BIOSCIENCES INC

ALMRNASDAQ

🏆 #1537 by market capUS Equity

$36.57▲ $11.21 (+30.65%)

Live

1h—

24h▲ 30.6%

7d—

14d—

30d—

1y—

🏦Market Cap

$2.53B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

No chart data available for ALMR.

Trading Snapshot

Day Range: $36.08 – $37.29
52-Week Range: $18.85 – $29.43
Volume: $3.87B
Avg Volume: $3.42B
Shares Outstanding: 69.3M
Next Earnings: Oct 3, 2026

Fundamentals Snapshot

Annual Revenue: $74M
Last Q Revenue: $29M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): —
Dividend Yield: —

Why Investors Own ALMR

✓High-growth profile — revenue up +47.3% YoY with expanding US Equity exposure.
✓Healthy economics — 34% gross margin and 9% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$74M▲ +49.3% YoY

Gross Margin (TTM)

33.7%▲ +1.4% YoY

Operating Income (TTM)

$22M▲ +49.3% YoY

Free Cash Flow (TTM)

$7M▲ +49.3% YoY

About ALAMAR BIOSCIENCES INC

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

🦦